Compare GE Vernova Inc (GEV) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? GE Vernova Inc trades at $909.23 (market cap $250.83B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: GE Vernova Inc is far larger — about 49.4× Oruka Therapeutics Inc. Common Stock's market cap, and GE Vernova Inc pays a 0.21% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Vernova Inc for 37 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| GEV | ORKA | |
|---|---|---|
Market Cap | $250.83B | $5.08B |
Volume | 3,491,026 | 685,276 |
Sector | Industrials | Health |
52-Week High | $1.17K | $113.08 |
52-Week Low | $547.96 | $26.19 |
Typical Hold Time | 37 Days | 0 Days |
Enterprise Value | $240.50B | $4.21B |
Dividend Yield | 0.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $1,004.04, up 0.73% with strong technical momentum and bullish moving averages. The company shows impressive fundamentals with 23% net income margin and 91% ROE, though valuation multiples appear elevated. Recent Q2 earnings missed expectations, but analyst consensus remains strongly bullish with a $1,270 price target. The company secured the first US construction permit for its BWRX-300 small modular reactor, positioning it for AI-driven power demand growth.
GEV offers exposure to the accelerating AI power infrastructure theme with a $176 billion backlog, but faces execution risks in its wind segment and valuation concerns. The stock's 45% YTD gain reflects optimism about nuclear energy adoption, though profitability consistency remains key for further upside. Near-term resistance sits at $1,010-$1,017 with support at $990-$984.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
